摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

vanilin thiosemicarbazone | 1489265-31-7

中文名称
——
中文别名
——
英文名称
vanilin thiosemicarbazone
英文别名
vanilline thiosemicarbazone;2-(4-hydroxy-3-methoxybenzylidene)hydrazinecarbothioamide;(E)-2-(4-hydroxy-3-methoxybenzylidene)hydrazinecarbothioamide;Semicarbazide, 1-(4-hydroxy-3-methoxybenzylidene)-3-thio-;[(E)-(4-hydroxy-3-methoxyphenyl)methylideneamino]thiourea
vanilin thiosemicarbazone化学式
CAS
1489265-31-7;5351-92-8
化学式
C9H11N3O2S
mdl
——
分子量
225.271
InChiKey
FJQYXPHDGKUTQE-VZUCSPMQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    197 °C
  • 沸点:
    412.2±55.0 °C(Predicted)
  • 密度:
    1.35±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    112
  • 氢给体数:
    3
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    vanilin thiosemicarbazone2-氯乙酰乙酸乙酯乙醇 为溶剂, 以88%的产率得到ethyl 2-[(E)-2-[(4-hydroxy-3-methoxyphenyl)methylidene]hydrazin-1-yl]-4-methyl-1,3-thiazole-5-carboxylate
    参考文献:
    名称:
    2-(2-Hydrazinyl)thiazole derivatives: Design, synthesis and in vitro antimycobacterial studies
    摘要:
    In an attempt to discover new potent inhibitors for Mycobacterium tuberculosis (Mtb), a series of 2-(2hydrazinyl)thiazole derivatives with a wide range of substitutions at 2-, 4- and 5-positions were designed by considering Lipinski rule. The designed compounds were synthesized, characterized and evaluated for their inhibitory potential against Mtb, H(37)Rv, by in vitro assay. The compounds, ethyl-4methyl-2-[(E)-24]-(pyridin-2-yl)ethylidene]hydrazin-1-yl]-1,3-thiazole-5-carboxylate, 4d, and ethyl-2[(E)-2-[(2-hydroxyphenyl)methylidenelhydrazin-1-yl]-4-methyl-1,3-thiazole-5-carboxylate, 2i showed noticeable inhibitory activity against Mtb, H37Rv with minimum inhibitory concentration (MIC) of 12.5 pM and 25 1.1M respectively. An attempt has been made to understand the mechanism of action by binding interactions of these molecules with 0-ketoacyl-ACP synthase protein through docking studies. The inhibition constants for compounds 4d and 2i were found to be 1.46 pM and 0.177 pM respectively. (C) 2013 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2013.08.054
  • 作为产物:
    描述:
    香草醛氨基硫脲溶剂黄146 作用下, 以 乙醇 为溶剂, 反应 24.0h, 以54%的产率得到vanilin thiosemicarbazone
    参考文献:
    名称:
    Synthesis and Single-Crystal X-Ray Diffraction Studies of an Arylidenethiosemicarbazone and Hydrazonyl-phenylthiazole
    摘要:
    芳香醛与氨基硫脲反应生成亚苯基酰肼硫酰胺,其与苯乙酰溴反应生成(亚苯基酰肼基)-4-苯基噻唑。通过1H-NMR和质谱技术全面表征了3和7的结构。光谱分析与所指派的结构一致。所指派的结构进一步得到了单晶X射线衍射研究的支持,总结如下:3为三斜晶系,P-1空间群,a=7.6319(4) Å,b=8.7099(4) Å,c=10.7145(5) Å,α=77.7400(10)°,β=74.0160(10)°,γ=72.8270(10)°,V=647.47(5) ų,Z=2;7为正交晶系,Pna21空间群,a=9.3760(13) Å,b=14.029(2) Å,c=23.591(3) Å,α=90°,β=90°,γ=90°,V=3103.0(7) ų,Z=4。
    DOI:
    10.2174/15701786113106660065
点击查看最新优质反应信息

文献信息

  • Gold complexes with thiosemicarbazones: reactions of bi- and tridentate thiosemicarbazones with dichloro[2-(dimethylaminomethyl)phenyl-C 1,N ]gold(III), [Au(damp-C 1,N )Cl2]
    作者:Ulrich Abram、Kirstin Ortner、Ronald Gust、Klaus Sommer
    DOI:10.1039/a908712e
    日期:——
    Dichloro[2-(N,N-dimethylaminomethyl)phenyl-C1,N]gold(III), [Au(damp-C1,N)Cl2] (1), reacts with salicylaldehyde thiosemicarbazone (H2saltsc), vanilline thiosemicarbazone (Hvantsc), N-methylpyrrole aldehyde thiosemicarbazone (Hmepyrtsc), pyridoxal methylthiosemicarbazone (H2pydoxmetsc), 2-diphenylphosphinobenzaldehyde thiosemicarbazone (HPtsc) or variously substituted acetylpyridine thiosemicarbazones (HapRtsc; R = H, Me, Ph) with cleavage of the Au–N bond and protonation of the dimethylamino group. Compounds of general formulae [Au(Hdamp-C1)Cl(L)]+ (L = Hsaltsc−, vantsc−, mepyrtsc−), [Au(Hdamp-C1)Cl(L)]2+ (L = H2pydoxmetsc) or [Au(Hdamp-C1)(L)]2+ (L = Ptsc−, apRtsc−, R = H, Me, Ph) have been isolated and characterized. The presence of the σ-bonded 2-(dimethylaminomethyl)phenyl ligand is mandatory to prevent reduction of the gold(III) centre. The crystal structures of [Au(Hdamp-C1)Cl(Hsaltsc)](PF6) (3a), [Au(Hdamp-C1)Cl(mepyrtsc)]Cl (3c), [Au(Hdamp-C1)Cl(H2pydoxmetsc)]Cl2·MeOH (4), [Au(Hdamp-C1)(apPhtsc)]Cl2·2 MeOH (5c) and [Au(Hdamp-C1)(Ptsc)]Cl2· 1.5MeOH (6) have been elucidated, showing the gold atoms in distorted square-planar co-ordination environments. The potentially O,N,S-tridentate ligands H2saltsc and H2pydoxmetsc co-ordinate in a bidentate fashion and do not incorporate the OH groups in the chelating framework, whereas HapRtsc or HPtsc co-ordinate in a tridentate manner. Generally, one or more hydrogen atoms of the heterocyclic ligands and/or the NMe2H+ group form hydrogen bridges in the solid state structures. The preliminary results of antiproliferation tests on tumor cells demonstrate the considerable cytotoxicity of these new gold complexes. p
    二氯[2-(N,N-二甲氨基甲基)苯-C1,N]金(III), [Au(damp-C1,N)Cl2] (1), 与水杨醛缩氨基硫脲(H2saltsc), 香草醛缩氨基硫脲(Hvantsc), N-甲基吡咯醛缩氨基硫脲(Hmepyrtsc), 吡哆醛缩甲基氨基硫脲(H2pydoxmetsc), 2-二苯基膦基苯甲醛缩氨基硫脲(HPtsc)或者各种取代的乙酰吡啶缩氨基硫脲(HapRtsc; R = H, Me, Ph)反应, 导致Au–N键断裂并使二甲氨基质子化. 根据通式[Au(Hdamp-C1)Cl(L)]+(L = Hsaltsc−, vantsc−, mepyrtsc−), [Au(Hdamp-C1)Cl(L)]2+(L = H2pydoxmetsc), 或者[Au(Hdamp-C1)(L)]2+(L = Ptsc−, apRtsc−, R = H, Me, Ph)分离并表征得到化合物. 为了防止金(III)中心的还原, 必须存在σ键合的2-(二甲氨基甲基)苯配体. 通过测定[Au(Hdamp-C1)Cl(Hsaltsc)](PF6) (3a), [Au(Hdamp-C1)Cl(mepyrtsc)]Cl (3c), [Au(Hdamp-C1)Cl(H2pydoxmetsc)]Cl2·MeOH (4), [Au(Hdamp-C1)(apPhtsc)]Cl2·2 MeOH (5c)和[Au(Hdamp-C1)(Ptsc)]Cl2· 1.5MeOH (6)的晶体结构, 发现金原子处于扭曲的平面四边形配位环境. 潜在的O,N,S-三齿配体H2saltsc和H2pydoxmetsc以二齿的形式配位, 没有把羟基包含在螯合骨架中, 然而HapRtsc或HPtsc以三齿的形式配位. 通常, 杂环配体的一个或者多个氢原子和/或者NMe2H+形成氢键出现在固态结构中. 对肿瘤细胞的抗增殖试验的初步结果表明这些新金配合物具有较大的细胞毒性.
  • Aryl hydrazones linked thiazolyl coumarin hybrids as potential urease inhibitors
    作者:Uzma Salar、Bakhtawer Qureshi、Khalid Mohammed Khan、Muhammad Arif Lodhi、Zaheer Ul‑Haq、Farman Ali Khan、Fouzia Naz、Muhammad Taha、Shahnaz Perveen、Shafqat Hussain
    DOI:10.1007/s13738-021-02377-8
    日期:2022.4
    Aryl hydrazones bearing thiazolyl coumarin hybrids 1–32 were prepared by following 'one-pot' two-steps reaction scheme. Various arylaldehydes were reacted to thiosemicarbazide under acidic condition to form aryl thiosemicarbazone intermediates which in turn treated with 3-bromoacetyl coumarin under basic condition to afford thiazolyl coumarin hybrids 1–32. All hybrids were recognized by EI- and HREI-MS
    通过遵循“一锅”两步反应方案制备带有噻唑基香豆素杂化物1-32的芳基腙。各种芳醛在酸性条件下与氨基硫脲反应形成芳基氨基氨基硫脲中间体,该中间体又在碱性条件下用 3-溴乙酰香豆素处理,得到噻唑基香豆素杂化物 1-32。所有杂种均通过 EI-和 HREI-MS 以及 1H-和 13C-NMR 光谱技术进行识别。筛选化合物 1-32 对脲酶的体外抑制活性,并在 IC50 = 16.29 ± 1.1-256.30 ± 1.4 µM 范围内显示出良好至中等的抑制潜力。值得指出的是,化合物 21 (IC50 = 16.29 ± 1.1 µM) 被确定为比标准乙酰氧肟酸 (IC50 = 27.0 ± 0.5 µM) 更有效的脲酶抑制剂。衍生物 19 (IC50 = 77.67 ± 1. 5 µM) 和 30 (IC50 = 71.21 ± 1.6 µM) 被发现具有中度活性。构效关系表明-F、-Cl、-
  • Aryl thiosemicarbazones for the treatment of trypanosomatidic infections
    作者:Pasquale Linciano、Carolina B. Moraes、Laura M. Alcantara、Caio H. Franco、Bruno Pascoalino、Lucio H. Freitas-Junior、Sara Macedo、Nuno Santarem、Anabela Cordeiro-da-Silva、Sheraz Gul、Gesa Witt、Maria Kuzikov、Bernhard Ellinger、Stefania Ferrari、Rosaria Luciani、Antonio Quotadamo、Luca Costantino、Maria Paola Costi
    DOI:10.1016/j.ejmech.2018.01.043
    日期:2018.2
    interesting activity against the same organisms. The compounds were particularly effective against T. brucei and T. cruzi. Among the 28 synthesized compounds, the best one was (E)-2-(4-((3.4-dichlorobenzyl)oxy)benzylidene) hydrazinecarbothioamide (A14) yielding a comparable anti-parasitic activity against the three parasitic species (TbEC50 = 2.31 μM, LiEC50 = 6.14 μM, TcEC50 = 1.31 μM) and a Selectivity Index
    基于显示出抗锥虫病活性的噻二唑衍生物库,我们已经考虑了噻二唑的开放形式和反应中间体硫代半脲类化合物,作为针对布鲁氏锥虫(Tb),婴儿利什曼原虫(Li)和克氏锥虫(Tc)。相似的化合物已经显示出对相同生物的有趣活性。该化合物对T. brucei和T. cruzi特别有效。在这28种合成的化合物中,最好的一种是(E)-2-(4-((3.4-二氯苄基)氧基)亚苄基)肼基甲硫代酰胺(A14)针对三种寄生物(Tb EC 50  = 2.31μM,Li EC 50  = 6.14μM,Tc EC 50  = 1.31μM )产生可比的抗寄生虫活性,并且相对于人类巨噬细胞的选择性指数高于10,因此显示泛抗锥虫病活动。(E)-2-(((3'.4'-二甲氧基-[1.1'-联苯] -3-基]甲基)甲基)肼基甲硫代酰胺(A12)和(E)-2-(4-((3.4-二氯苄基)氧基)苯亚甲基)肼硫代甲酰胺(A14)在组
  • Verfahren zur Verbesserung der Löslichkeit biologisch aktiver Wirkstoffe in Wasser und niederen aliphatischen Alkoholen sowie neue Verbindungen mit verbesserter Löslichkeit
    申请人:BAYER AG
    公开号:EP0017772A1
    公开(公告)日:1980-10-29
    Die vorliegende Erfindung betrifft ein neues Verfahren zur Verbesserung der Löslichkeit biologisch aktiver Wirkstoffe mit mindestens einem Zerewitinoff-aktiven Wasserstoffatom in Wasser und niederen aliphatischen Alkoholen, neue nach diesem Verfahren hergestellte Verbindungen und ihre Verwendung, dadurch gekennzeichnet, dass man Wirkstoffe, OH, NH, NH2-monofunktionelle Polyether mit einem Wasseraufnahmevermögen von 10% und Verbindungen mit 2 gegenüber Zerewitinoff-aktiven Wasserstoffatomen reaktiven Gruppen miteinander umsetzt.
    本发明涉及一种新工艺,用于提高具有至少一个泽勒维蒂诺夫活性氢原子的生物活性剂在水和低级脂肪醇中的溶解度;通过该工艺制备的新化合物及其用途,其特征在于活性剂、OH、NH、吸水能力为10%的NH2-单官能团聚醚和具有2个对泽勒维蒂诺夫活性氢原子起反应的基团的化合物相互反应。
  • Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models
    作者:A.L. Zakharenko、O.A. Luzina、D.N. Sokolov、V.I. Kaledin、V.P. Nikolin、N.A. Popova、J. Patel、O.D. Zakharova、A.A. Chepanova、A. Zafar、J. Reynisson、E. Leung、I.K.H. Leung、K.P. Volcho、N.F. Salakhutdinov、O.I. Lavrik
    DOI:10.1016/j.ejmech.2018.10.055
    日期:2019.1
    The druggability of the tyrosyl-DNA phosphodiesterase 1 (Tdp1) enzyme was investigated in conjunction with topoisomerase 1 inhibition. A novel class of thiazole, aminothiazole and hydrazonothiazole usnic acid derivatives was synthesized and evaluated as Tdp1 inhibitors and their ability to sensitize tumors to topotecan, a topoisomerase inhibitor in clinical use. Of all the compounds tested, four hydrazinothiazole derivatives, 20c, 20d, 20h and 20i, inhibited the enzyme in the nanomolar range. The activity of the compounds was verified by affinity experiments as well as supported by molecular modelling. The most effective Tdp1 inhibitor, 20d, was ton-toxic and increased the effect of topotecan both in vitro and in vivo in the Lewis lung carcinoma model. Furthermore, 20d showed significant increase in the antitumor and antimetastatic effect of topotecan in mice. The results presented here justify compound 20d to be considered as a drug lead for antitumor therapy. (C) 2018 Elsevier Masson SAS. All rights reserved.
查看更多